NIRALI PATEL

Allopathic & Osteopathic Physicians|Internal Medicine GENEVA, IL NPI 1720115041

General Payments — all program years on this page

$1,051.56

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 55
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $435.21 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $435.2122

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $113.667
2019 $122.547
2020 $67.284
2022 $13.261
2023 $299.6114
2024 $435.2122

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089514118 Currax Pharmaceuticals LLC $15.72 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089514120 Currax Pharmaceuticals LLC $13.14 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089514122 Currax Pharmaceuticals LLC $17.09 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097000514 Novo Nordisk Inc $20.95 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104464124 AstraZeneca Pharmaceuticals LP $23.11 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105197912 ABBVIE INC. $23.90 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105197914 ABBVIE INC. $19.84 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105197916 ABBVIE INC. $23.15 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105197918 ABBVIE INC. $15.42 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114826458 Exact Sciences Corporation $22.19 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116412717 GlaxoSmithKline, LLC. $16.23 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116534524 GlaxoSmithKline, LLC. $34.05 01/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117649980 Amgen Inc. $14.62 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117649982 Amgen Inc. $16.39 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117649984 Amgen Inc. $17.93 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117649986 Amgen Inc. $18.29 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117649988 Amgen Inc. $16.81 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118958488 Otsuka America Pharmaceutical, Inc. $17.58 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135241903 Lilly USA, LLC $29.50 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135241908 Lilly USA, LLC $14.42 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135259723 Lilly USA, LLC $30.53 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151107776 Phathom Pharmaceuticals, Inc. $14.35 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.